BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Sep 11, 15:57Prev. Close
12.05
Open Price
12.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.59 (427)
Balance Sheet of Vaishali Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 26.09 | 10.72 | 10.55 | 10.55 | 10.55 | |
Total Share Capital | 26.09 | 10.72 | 10.55 | 10.55 | 10.55 | |
Reserves and Surplus | 38.82 | 25.09 | 22.43 | 15.81 | 11.87 | |
Total Reserves and Surplus | 38.82 | 25.09 | 22.43 | 15.81 | 11.87 | |
Total Shareholders Funds | 64.92 | 35.81 | 32.97 | 26.35 | 22.42 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 4.20 | 3.60 | 5.23 | 3.11 | 4.26 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 0.68 | 0.24 | 0.88 | 0.04 | 0.00 | |
Long Term Provisions | 0.00 | 0.20 | 0.19 | 0.19 | 0.18 | |
Total Non-Current Liabilities | 4.87 | 4.03 | 6.30 | 3.33 | 4.44 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 7.46 | 9.01 | 8.44 | 17.66 | 11.67 | |
Trade Payables | 27.14 | 19.39 | 18.00 | 28.38 | 40.54 | |
Other Current Liabilities | 5.43 | 4.66 | 5.61 | 5.87 | 7.03 | |
Short Term Provisions | 0.01 | 0.03 | 0.02 | 0.03 | 0.02 | |
Total Current Liabilities | 40.05 | 33.08 | 32.07 | 51.94 | 59.26 | |
Total Capital And Liabilities | 109.84 | 79.96 | 78.90 | 81.62 | 86.12 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1.41 | 1.46 | 1.80 | 0.90 | 0.72 | |
Intangible Assets | 0.67 | 0.06 | 0.18 | 0.28 | 0.50 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 2.08 | 2.26 | 2.65 | 1.67 | 1.26 | |
Non-Current Investments | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | |
Deferred Tax Assets [Net] | 0.18 | 0.18 | 0.14 | 0.16 | 0.15 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 2.66 | 2.57 | 3.00 | 2.93 | 2.99 | |
Total Non-Current Assets | 5.36 | 5.44 | 6.23 | 5.20 | 4.83 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 4.81 | 0.38 | 3.05 | 0.63 | 0.59 | |
Trade Receivables | 46.72 | 49.43 | 53.61 | 58.51 | 66.73 | |
Cash And Cash Equivalents | 1.84 | 1.58 | 0.98 | 1.36 | 0.47 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 51.11 | 23.13 | 15.03 | 15.94 | 13.51 | |
Total Current Assets | 104.48 | 74.52 | 72.67 | 76.43 | 81.29 | |
Total Assets | 109.84 | 79.96 | 78.90 | 81.62 | 86.12 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 2.03 | 5.50 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 18.43 | 17.55 | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | 6.45 | 6.45 | 6.45 | 0.00 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 0.43 | 0.43 | 0.43 | 0.43 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y